Intensive intervention can lead to a treatment holiday from biological DMARDs in patients with rheumatoid arthritis
Abstract
Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by inflammation and joint destruction that causes significant morbidity and mortality. However, the combined use of methotrexate (MTX), a synthetic disease-modifying anti-rheumatic drug (sDMARD) and biological DMARDs (bDMARDs) …
Keywords
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
review
humans
pubmed abstract
nih
national institutes of health
national library of medicine
arthritis
pmid:25389048
pmc4245498
doi:10.1007/s40265-014-0323-4
yoshiya tanaka
shintaro hirata
antirheumatic agents / pharmacology*
rheumatoid* / drug therapy
rheumatoid* / physiopathology
immunosuppressive agents / pharmacology
medication therapy management / trends
methotrexate / pharmacology
patient acuity
remission induction / methods*
withholding treatment / trends*
Access
Citation
ID:
112676
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
112676
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet